Medindia
Advertisement

Drug for Treatment of AIDS Awaits FDA Approval

by Julia Samuel on January 21, 2015 at 3:48 PM
Font : A-A+

Drug for Treatment of AIDS Awaits FDA Approval

Banglore-based Strides Arcolab and Gilead Sciences have signed a licensing agreement under which Gilead has extended non-exclusive rights to Strides to make and distribute Tenofovir Alafenamide (TAF), both as a single agent product and in combination with other drugs.

TAF is a novel nucleotide reverse transcriptase inhibitor used in human immunodeficiency virus (HIV) patients in the treatment of acquired immunodeficiency syndrome (AIDS).

Advertisement

TAF is awaiting U.S. Food and Drug Administration (FDA) approval, and is expected to go to market by year-end.

Strides will receive a technology transfer from Gilead, enabling it to make low-cost versions of TAF for developing countries.

A statement from Strides said the licence extends to 112 countries, which together account for more than 30 million people living with HIV.
Advertisement

Strides will be able to launch its product by mid-2016. TAF has demonstrated high antiviral efficacy at a dose 10 times lower than Gilead's Viread (tenofovir disoproxil fumarate), as well as an improved renal and bone safety profile, the statement said.

In September, 2014, Gilead signed agreements with seven Indian generic drug manufacturers licensing them to make sofosbuvir to supply it to 90 countries. Sofosbuvir is priced at $84,000 per patient in the U.S., and the effective price for generic version is around $900 and a 10 percent royalty.

D.G. Shah, Secretary-General, Indian Pharmaceutical Alliance said, "Gilead's chosen voluntary licensing model is refreshing, and will certainly earn it goodwill. It ensures protection of intellectual property and simultaneously ensures access to medicines. Today, its TAF licensing announcement is just an extension of its existing model for developing markets."

"Pharmaceutical multinational prefer Indian manufacturers over other generic manufacturing destinations like South Africa and Brazil because India is already supplying generics to 200 countries and has proven capability, cost-effectiveness and quality," Mr. Shah said.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sedentary Behavior Precipitates Night-Time Hot Flashes
Gonorrhea
World Alzheimer's Day 2021 - 'Know Dementia, Know Alzheimer's
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs AIDS - Initial Theories and Disease Progression 

Recommended Reading
AIDS / HIV - Treatment
Encyclopedia section of medindia explains in brief about the treatment for AIDS/HIV...
AIDS/HIV - Clinical Features
Encyclopedia section of medindia gives general info about HIV Clinical Features...
It's Not the End of the Road for HIV Patients
HIV patients can lead a normal life if they maintain a positive attitude....
AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV...
AIDS - Initial Theories and Disease Progression
AIDS was first detected in early 1980s, among gays, Haitians and black Africans. HIV is a descendant...
AIDS/HIV
"AIDS is an epidemic disease, a potentially preventable, deadly infection for which there is no cure...
AIDS/HIV - Epidemiology
AIDS or HIV is an epidemic disease, a potentially deadly infection that can be prevented with preca...
AIDS/HIV - Health Education
Encyclopedia section of medindia gives general info about AIDS information and health education....
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Oral Health And AIDS
AIDS has taken on massive proportions in modern times. It is estimated that over 15 million people a...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use